chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Neck pain, Pain, Vision blurred
Clinical narrative: Body aches; Persisting neck pain; Blurred vision in left eye; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on 01Jun2021 at 17:30 (at the age of 29-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none and the patient did not have a history of allergies to any food or medications or other products. The patient did not receive any other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 02Jun2021, next day after vaccination, the patient experienced blurred vision in left eye, persisting neck pain for multiple days. On 03Jun2021 day after vaccination, the patient experienced body aches. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the events. The clinical outcome of the events blurred vision in left eye, body aches and persisting neck pain were not resolved at the time of this report.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Cognitive disorder, Headache
Clinical narrative: Cognitive issues (fogginess, short term memory retention, noticeable reduction in motor control, difficulty maintaining conversation and threading thoughts, forming sentences, etc.); Persistent headache; This is a spontaneous report from a non-contactable consumer, the patient. A 32-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 02Jun2021 at 16:30 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history included crohn's. Concomitant medication included adalimumab (HUMIRA) from an unknown date and for an unknown indication. The patient previously received cefixime (SUPRAX) on an unknown date and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Jun2021 at 09:00, the patient experienced cognitive issues (fogginess, short term memory retention, noticeable reduction in motor control, difficulty maintaining conversation and threading thoughts, forming sentences, etc.) and persistent headache. The patient did not have these cognitive problems normally. The patient's persistent headache did not respond to Tylenol. The patient did get periodic headaches but they did not last that long. Therapeutic measures were not taken as a result of cognitive issues. The clinical outcome of the events cognitive issues (fogginess, short term memory retention, noticeable reduction in motor control, difficulty maintaining conversation and threading thoughts, forming sentences, etc.) and persistent headache was not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: Blurry vision on right peripheral; This is a spontaneous report from a non-contactable consumer, the patient. A 15-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 04Jun2021 at 09:15 (at the age of 15-years-old), as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient did not have any allergies to medications, food, or other products. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 04Jun2021 at 09:30, the patient experienced blurry vision on right peripheral. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event blurry vision on right peripheral was recovered on 04Jun2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Musculoskeletal stiffness, Pyrexia
Clinical narrative: Stiff neck; Swollen lymph nodes; High fever; This is a spontaneous report from a contactable healthcare professional, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 01Jun2021 at 17:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high (HBP). The patient had known allergies to sulfa, fish and seafood. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included paracetamol (TYLENOL) and ibuprofen (MOTRIN); both from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 11May2021 at 18:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Jun2021 at 15:00, the patient experienced stiff neck, swollen lymph nodes and high fever. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events stiff neck, swollen lymph nodes and high fever was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: felt light headed and dizziness the next day after the injection.; This is a spontaneous report from a contactable consumer. A 16-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in May2021(at the age of 16-years-old) as a single dose and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 04Jun2021(at the age of 16-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and patient had known allergy (unspecified). It was not known whether the patient had other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was not known whether the patient received any other vaccines within four weeks prior to the vaccination. On an unknown date in May2021, the patient felt light headed and dizziness the next day after the injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. The clinical outcome of the event felt light headed and dizziness the next day after the injection was resolved on an unknown date in 2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Peripheral coldness
Clinical narrative: Fatigue causing 2-3 hour naps for 2 days; Very cold hands/ ice cold feet; This is a spontaneous report from a non-contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 28May2021 at 16:15 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included levothyroxine sodium (LEVOTHYROXIN) for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 23Apr2021 at 16:45 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29May2021 at 09:00, the patient experienced fatigue causing 2-3 hour naps for 2 days following plus 1-2 hrs resting after awakening. 1 day after, patient had very cold hands. After napping, had ice cold feet despite wearing sweatpants and being covered with a blanket while asleep. Therapeutic measures were taken as a result of the adverse events and included measures like napping for 3 hours, resting  1-2 hours and earlier bedtime. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fatigue causing 2-3 hour naps for 2 days and very cold hands/ ice cold feet were resolved on an unknown date in 2021.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Menstruation delayed
Clinical narrative: Missed period for two months; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Mar2021 at 07:30 (at the age of 28 years old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date, the patient experienced missed period for two months. Therapeutic measures were not taken as a result of the event. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event missed period for two months was resolved on an unknown date.   No follow-up attempts are possible; information about lot number cannot be obtained. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Haemorrhage, Pruritus
Clinical narrative: bleeding; itchy skin; bruises; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 15Apr2021 at 12:00 (at the age of 30-years-old) as a single dose and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on 15Apr2021 at 12:00 as a single dose for COVID-19 immunisation. Medical history included prior to the vaccination, the patient was diagnosed with COVID-19. Patient have family history of heart problems. The patient did not have any allergies to medications, food, or other products. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 18:00 the patient experienced itchy skin ever since she got the first shot and it had been a month since second vaccine and she had itchy skin like crazy and the patient itched until there were bruises and patient were bleeding. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of itchy skin and included treatment with Benadryl and allergy medication since an unknown start date to an unknown stop date. The clinical outcome of the event itchy skin, bruises,bleeding was not recovered at the time of this report.   The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow up.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: Heavy bloody nose; This is a spontaneous report from a contactable consumer, the parent. A 14-year-old non pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05Jun2021 at 12:00 (at the age of 14-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 15May2021 at 12:00 (at the age of 14-years-old), as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID -19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies to medications, food or other products. On 05Jun2021 at 12:00, the patient experienced heavy bloody nose within 5minutes of receiving vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event heavy bloody nose was recovered on 05Jun2021.   The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain in extremity, Pyrexia, Vomiting
Clinical narrative: fever; Chills; Sore arm; Next day woke up and threw up.; This is a spontaneous report from a non-contactable consumer, the patient. A 12-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Jun2021 at 09:15(at the age of 12-years-old) as a single dose for COVID-19 immunisation. Medical history included aspergers disorder and adhd. Patient had no known allergies to food, medications or other products. The patient received unspecified other medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15May2021 at 09:00(at the age of 12-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 06Jun2021 at 05:15, the patient woke up next day and threw up and had fever, chills and sore arm. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. On 06Jun2021, the patient body temperature was measured and the result was 101(units unspecified). The clinical outcome of the event woke up next day and threw up and had fever, chills and sore arm was recovering at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Palpitations
Clinical narrative: Chest was heavy; Heart was racing; This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04Jun2021 at 17:45 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received SEPTRA and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Jun2021 at 18:00 the patient's chest was heavy and heart was racing which she had never experienced before for which she ended up at the emergency room around 19:00. The event resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of chest heaviness and heart racing and included treatment with unknown medications for both blood pressure and heart. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events chest heaviness and heart racing were not recovered at the time of reporting.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Abdominal pain upper, Headache, Nausea, Pain
Clinical narrative: Severe headache; Pain at the injection site; Body aches severe; Digestive distress; Stomach ache; Feeling of needing to vomit; This is a spontaneous report from a non-contactable consumer, the patient. A 16-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0178) via an unspecified route of administration in the right arm on 03Jun2021 at 16:30 (at the age of 16 years old) as a single dose for COVID-19 immunisation. Medical history included peanut allergy and corn allergy. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 13May2021 at 16:15 (at the age of 15 years old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Jun2021 at 01:00, the patient experienced severe headache, pain at the injection site, body aches severe, digestive distress, stomach ache and the feeling of needing to vomit. Therapeutic measures were taken as a result of the events which included treatment with ADVIL. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events severe headache, pain at the injection site, body aches severe, digestive distress, stomach ache and the feeling of needing to vomiting was not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Severe headache; Pain at the injection site; Body aches severe; Digestive distress; Stomach ache; Feeling of needing to vomit; This is a spontaneous report from a non-contactable consumer, the patient. A 16-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0178) via an unspecified route of administration in the right arm on 03Jun2021 at 16:30 (at the age of 16 years old) as a single dose for COVID-19 immunisation. Medical history included peanut allergy and corn allergy. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 13May2021 at 16:15 (at the age of 15 years old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Jun2021 at 01:00, the patient experienced severe headache, pain at the injection site, body aches severe, digestive distress, stomach ache and the feeling of needing to vomit. Therapeutic measures were taken as a result of the events which included treatment with ADVIL. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events severe headache, pain at the injection site, body aches severe, digestive distress, stomach ache and the feeling of needing to vomiting was not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Blepharospasm
Clinical narrative: Persistent twitch of eyelid right eye; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 28May2021 at 12:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Concomitant medications included unspecified multivitamins from an unknown date and for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 07May2021 at 12:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Jun2021 at 09:00, the patient experienced persistent twitch of eyelid right eye. The patient did not receive any treatment for the reported event. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event persistent twitch of eyelid right eye was not resolved at the time of this report.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Hypertension, Limb discomfort, Palpitations, Paraesthesia
Clinical narrative: Tingling in legs, pins and needle in legs; hard heavy legs feeling; high blood presure; brain fog; heart palpations; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 14Feb2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was not reported. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was unknown if the patient had been tested for COVID-19 since the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Feb2021, the patient experienced tingling in legs, hard heavy legs feeling, pins and needle in legs, high blood pressure, brain fog and heart palpations. The events resulted in doctor or other healthcare professional office/clinic visit, emergency visit room/department or urgent care. Therapeutic measures were not taken as a result of adverse events. The clinical outcome of the events tingling in legs, hard heavy legs feeling, pins and needle in legs, high blood pressure, brain fog and heart palpations were resolving at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pyrexia, Vision blurred
Clinical narrative: moderate joint pain; low fever; blurred vision.; This is a spontaneous report from a non-contactable consumer, the patient. A 23-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 04Jun2021 at 14:15 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history included exercise induced asthma and allergy to gluten. Concomitant medications included quetiapine fumarate (SEROQUEL) from unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14May2021 at 13:15 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Jun2021 at 09:00, the patient experienced moderate joint pain, low fever and blurred vision. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events moderate joint pain, low fever and blurred vision was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Pain in extremity, Palpitations, Poor quality sleep
Clinical narrative: Very poor sleep; Sense of dread/  Worried that she was dying and heart was going to explode; Heart palpitating and racing; Very tired; Soreness in arm where the vaccine was injected; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN; lot unknown reason: other) via an unspecified route of administration on an unknown date (at the age of 33-year-old) as a single dose for COVID-19 immunisation. The patient medical history included bronchitic asthma, ventricular septal defect and heart murmur. The patient was allergic to latex. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Jun2021 at 05:15, the patient experienced very poor sleep, felt a sense of dread and then heart palpitating and racing, which woke her up. She was worried that she was dying and heart was going to explode, very tired and worried. This has been her only noticeable side effect besides soreness in her arm where the vaccine was injected. The clinical outcome of the events very poor sleep, felt a sense of dread and then heart palpitating and racing, which woke her up, she was worried that she was dying and heart was going to explode very tired and worried soreness in arm where the vaccine was injected was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Nausea
Clinical narrative: Monday morning I started to feel dizzy and nauseous; Monday morning I started to feel dizzy and nauseous; headache started almost immediately after receiving the vaccine; This is a spontaneous report from a contactable consumer (Patient) reporting for herself. A 36-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EW0217; Expiration date was not reported), via an unspecified route of administration, in Left Arm on 03Jun2021 15:00 (at the age of 36-years-old) as DOSE 1, SINGLE for covid-19 immunisation at Pharmacy or Drug store. The patient medical history included depression, panic disorder, injury, stress (trauma and stressor related disorder), asthma, glucose tolerance impaired (prediabetes), obesity from an unknown date and unknown if ongoing. The patient had no known allergies and the patient did not receive other vaccine in four weeks, The patient was not diagnosed covid prior vaccination, The patient had not been tested for covid, post vaccination. The patient concomitant medications included buspirone hydrochloride (BUSPAR); fluoxetine hydrochloride (PROZAC); loratadine (LORATADINE); fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]) taken for an unspecified indication, start and stop date were not reported. The patient experienced headache started almost immediately after receiving the vaccine on 03Jun2021, Monday morning patient started to feel dizzy and nauseous on 07Jun2021 07:00. The patient did not received treatment for the events. Clinical outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected
Age: 13.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Nausea
Clinical narrative: Chills; nausea; This is a spontaneous report from a contactable consumer, the patient. A 13-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on 03Jun2021(at the age of 13-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as unknown. It was unknown if patient had any allergies. It was unknown if patient received any other medication within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unknown route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. It was unknown if  the patient received any other vaccines within four weeks prior to the vaccination. On 04Jun2021, the patient experienced chills and nausea. It was unknown whether therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the event chills and nausea was resolved on an unknown date in Jun2021.   The batch/lot numbers for BNT162b2 was not provided and will be requested during follow up.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Anosmia
Clinical narrative: total distortion of smell/smells putrid and horrible; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old nonpregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 15Apr2021 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 in Jan2021. Concomitant medications were not reported. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021, the patient waited 3 months to get vaccinated and after the second vaccine had total distortion of smell. Everything smelled putrid and horrible. Coffee, onions, bread and much more smells horrible which made hard for to eat. This had really been a horrible experience and didn't happen until had the vaccine. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event total distortion of smell, everything smells putrid and horrible was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Urticaria, Vaccination site erythema, Vaccination site inflammation
Clinical narrative: red hives from wrist to above elbows on both arms less than 5 minutes after injection.; broke out in red hives from wrist to above elbows on both arms less than 5 minutes after injection.; week later the injection site was red; a week later the injection site was red and inflamed in about a half inch circle took over a week to heal.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 11Mar2021(at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus, TBI(traumatic brain injury) and heart blockage. The patient received other medications(unspecified) within two weeks of vaccination. The patient previously took amoxicillin, clavulanic acid (AUGMENTIN), metformin hydrochloride (GLUCOPHAGE), metformin(MANUFACTURER UNKNOWN) on unknown dates and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Mar2021 less than 5 minutes after injection, the patient experienced red hives from wrist to above elbows on both arms. On an unknown date in Mar2021 a week later,  the patient's injection site was red and inflamed in about a half inch circle and took over a week to heal and left a scar. Therapeutic measures were taken as a result of reported events which included treatment with Benadryl administered multiple doses by a pharmacist. The clinical outcome of the event red hives, the injection site red (vaccination site erythema) and inflamed in about a half inch circle (vaccination site inflammation) was recovered with sequelae on an unknown date in 2021 at the time of this report.   The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Painful swelling in armpit; This is a spontaneous report from a contactable consumer, the patient. A 14-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0191) via an unspecified route of administration in the left arm on 03Jun2021 at 16:00 (at the age of 14-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to peanut, treenut, shellfish and milk. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Jun2021, the patient experienced painful swelling in armpit. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event painful swelling in armpit was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Bone pain, Dizziness, Headache, Myalgia
Clinical narrative: 100F fever; very dizzy; nausea; strong headache; body ache (all muscles); body ache (all bones); This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 59267-1000-01) via an unspecified route of administration in the left arm on 03Jun2021 at 09:00 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 59267-1000-01) via an unspecified route of administration in the left arm on 13May2021 at 09:00 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Jun2021 at 20:00 the patient experienced 100F fever, very dizzy, nausea, strong headache, body ache (all muscles, all bones). On 03Jun2021, the patient checked body temperature and the result was 100F fever. The clinical outcome of the events 100F fever, very dizzy, nausea, strong headache, body ache (all muscles, all bones) was recovered with sequelae on 06Jun2021.   No follow-up attempts are possible. No further information is expected
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: 100F fever; very dizzy; nausea; strong headache; body ache (all muscles); body ache (all bones); This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 59267-1000-01) via an unspecified route of administration in the left arm on 03Jun2021 at 09:00 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 59267-1000-01) via an unspecified route of administration in the left arm on 13May2021 at 09:00 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Jun2021 at 20:00 the patient experienced 100F fever, very dizzy, nausea, strong headache, body ache (all muscles, all bones). On 03Jun2021, the patient checked body temperature and the result was 100F fever. The clinical outcome of the events 100F fever, very dizzy, nausea, strong headache, body ache (all muscles, all bones) was recovered with sequelae on 06Jun2021.   No follow-up attempts are possible. No further information is expected
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse event, Vertigo
Clinical narrative: Significant Vertigo starting 2 days after lasting for 3 weeks after each shot.; ''Apparent dopamine receptors blocked for the same time period''; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8733) via an unspecified route of administration in left arm on 30Mar2021 at 10:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on an unknown date in 2021 as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies. The patient did not receive any medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 01Apr2021 at 08:00, the patient had experienced significant vertigo starting 2 days after lasting for 3 weeks after each shot and ''apparent dopamine receptors blocked for the same time period.'' The symptoms stopped abruptly 3 weeks after each injection. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit emergency room/department or urgent care. Therapeutic measures were not taken as a result of adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event significant vertigo and ''apparent dopamine receptors blocked for the same time period'' was recovered on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pyrexia
Clinical narrative: Chills; Fever; Fatigue; This is a spontaneous report from a contactable consumer. A non-pregnant female patient of unknown age received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date the patient experienced chills, fever and fatigue for 48 hours. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care.  Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, fever and fatigue was resolved on an unknown date after 48 hours.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Rash pruritic
Clinical narrative: Itchy, bumpy, red rash on my legs, 10 days after vaccinated; Itchy, bumpy, red rash on my legs, 10 days after vaccinated; This is a spontaneous report from a contactable consumer. A 61-years-old non pregnant female patient received (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot number EW0167), via an unspecified route of administration on 25May2021 at 16:30 (at the age of 61-years-old) into left arm as single dose for COVID-19 immunization. Medical history included high cholesterol, allergies to penicillin. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks. The patient did not receive any other vaccines within 2 weeks prior to the COVID vaccine.  Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 04Jun2021 at 07:00 AM, the patient experienced itchy, bumpy, red rash on my legs, 10 days after vaccinated. The patient did not receive any treatment for the events. The outcome of the events was not recovered.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Tremor, Vomiting
Clinical narrative: 12 hours after vaccine vomiting; fever; body aches; tremors; This is a spontaneous report from a contactable consumer (patient). A 15-years-old female Non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EW0180), dose 2 via an unspecified route of administration, administered in Arm Left on 06Jun2021 at 10:45 (at the age of 15-years-old) as a DOSE 2, SINGLE for covid-19 immunisation at Pharmacy or Drug Store. The patient medical history included asthma from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: Ew0177), dose 1 via an unspecified route of administration, administered in Arm Left on 16May2021 at 12:00 PM, (at the age of 15-years-old) as a DOSE 1, SINGLE for covid-19 immunisation. The patient did not have Known allergies. No other vaccine was received in four weeks prior to vaccination. Other medications received in two weeks were none. Patient did not have COVID prior vaccination and not tested for COVID post vaccination. On 06Jun2021 23:00, 12 hours after vaccine patient had vomiting, fever, body aches and tremors. No treatment was received for the events. Outcome of the events were not recovered.  No follow-up attempts are possible. No further information is expected.  Follow-Up (19Jul2021): Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Breast mass, Feeling jittery, Hypertension, Lymphadenopathy, Palpitations
Clinical narrative: 1 week after 2nd vaccine, healthy female with lump in left breast,; requiring repeat mammograms, that was determined to be a swollen lymph node related to the vaccine.; Palpitations; jitters; high blood pressure; This is a spontaneous report from a contactable other health care professional (patient). A 56-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EN6201) via an unspecified route of administration in left arm on 19Feb2021 9:30 AM as dose 2 single for COVID-19 immunisation. The patient's medical history was not reported. Concomitant medications in two weeks included colecalciferol (VITAMIN D) Supplement. Patient was not pregnant. No other vaccine in four weeks. Patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9261) in left arm on 25Jan2021 09:00 am as dose 1 single for COVID-19 Immunization. It was reported that 1 week after 2nd vaccine healthy female with lump in left breast, requiring repeat mammograms, that was determined to be a swollen lymph node related to the vaccine. Palpitations, jitters and high blood pressure within 1 week of the 2nd vaccine all on 25Feb2021 x 8 weeks requiring a Cardiology Consult with Calcium Scoring, Echo, and Heart Monitor. All results were normal in Feb2021 and symptoms resolved within 8 weeks so cardiac symptoms were also determined to be related to the vaccine. Adverse events resulted in Doctor or other healthcare professional office/clinic visit. Adverse events treatment included 3 Mammograms, Echo, Calcium Scoring, Heart Monitor. No covid prior vaccination. No covid tested post vaccination. The outcome of all events was recovered in 2021.  No follow-up attempts are possible. No further information is expected.